- Open Access
Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1
- Chaitanya Kurhade1,
- Loreen Zegenhagen2,
- Elvira Weber1, 7,
- Sharmila Nair2, 8,
- Kristin Michaelsen-Preusse3,
- Julia Spanier4,
- Nelson O Gekara5,
- Andrea Kröger†2, 6 and
- Anna K Överby†1Email author
© Kurhade et al. 2016
- Received: 28 October 2015
- Accepted: 19 January 2016
- Published: 27 January 2016
Although type I interferons (IFNs)—key effectors of antiviral innate immunity are known to be induced via different pattern recognition receptors (PRRs), the cellular source and the relative contribution of different PRRs in host protection against viral infection is often unclear. IPS-1 is a downstream adaptor for retinoid-inducible gene I (RIG-I)-like receptor signaling. In this study, we investigate the relative contribution of IPS-1 in the innate immune response in the different brain regions during infection with tick-borne encephalitis virus (TBEV), a flavivirus that causes a variety of severe symptoms like hemorrhagic fevers, encephalitis, and meningitis in the human host.
IPS-1 knockout mice were infected with TBEV/Langat virus (LGTV), and viral burden in the peripheral and the central nervous systems, type I IFN induction, brain infiltrating cells, and inflammatory response was analyzed.
We show that IPS-1 is indispensable for controlling TBEV and LGTV infections in the peripheral and central nervous system. Our data indicate that IPS-1 regulates neuropathogenicity in mice. IFN response is differentially regulated in distinct regions of the central nervous system (CNS) influencing viral tropism, as LGTV replication was mainly restricted to olfactory bulb in wild-type (WT) mice. In contrast to the other brain regions, IFN upregulation in the olfactory bulb was dependent on IPS-1 signaling. IPS-1 regulates basal levels of antiviral interferon-stimulated genes (ISGs) like viperin and IRF-1 which contributes to the establishment of early viral replication which inhibits STAT1 activation. This diminishes the antiviral response even in the presence of high IFN-β levels. Consequently, the absence of IPS-1 causes uncontrolled virus replication, in turn resulting in apoptosis, activation of microglia and astrocytes, elevated proinflammatory response, and recruitment of inflammatory cells into the CNS.
We show that LGTV replication is restricted to the olfactory bulb and that IPS-1 is a very important player in the olfactory bulb in shaping the innate immune response by inhibiting early viral replication and viral spread throughout the central nervous system. In the absence of IPS-1, higher viral replication leads to the evasion of antiviral response by inhibiting interferon signaling. Our data suggest that the local microenvironment of distinct brain regions is critical to determine virus permissiveness.
- Tick-borne encephalitis
- Olfactory bulb
- Type I interferons
- Antiviral mechanism
- Immune evasion
The type I interferon system is the first line of defense against virus infections [1–5]. During viral replication, RNA intermediates are generated and recognized by distinct host pattern recognition receptors (PRRs). Two classes of PRRs, endosomal toll-like receptors (TLR) and cytoplasmic retinoid-inducible gene I (RIG-I)-like receptors (RLRs), are essential for the detection and protection against viral infection. However, the specific PRRs involved in mediating antiviral response are likely to be virus and cell type-specific [6–8]. Endosomal TLR3 and TLR7 recognize viral double-stranded RNA (dsRNA) and single-stranded DNA (ssRNA) and signal through their adaptor proteins TRIF (TLR3) and Myd88 (TLR7) to induce type I interferons (IFNs) via transcription factors IRF3 and IRF7, respectively . RLRs such as RIG-I and melanoma differentiation antigen 5 (MDA5) are double stranded RNA binding DExD/H box RNA helicases [10, 11]. After the recognition of viral RNA, they interact with mitochondrial associated adaptor protein interferon -β promoter stimulator 1 (IPS-1; also known as MAVS, VISA, or CARDIF) [12–15]. This interaction leads to downstream signaling and activation of transcription factors IRF3 and NF-κB, which translocate to the nucleus and activate type I IFN and proinflammatory genes [16, 17].
Type I IFNs are locally produced in the central nervous system (CNS) upon viral infection. The producing cell types differ from parenchymal cells upon influenza and La Crosse virus to astrocytes upon vesicular stomatitis virus (VSV) infection [18–20]. However, very little is known about the importance and the relative contribution of the different PRRs in the different regions of the CNS for protection against neurotropic viruses.
Tick-borne encephalitis virus (TBEV) is one of the emerging arthropod-borne viral (arboviral) diseases in Europe and Asia. It is a neurotropic-enveloped RNA virus of the Flaviviridae family and closely related to other human pathogens such as yellow fever virus, dengue virus, West Nile virus (WNV), Japanese encephalitis virus (JEV), and Murray Valley encephalitis virus . The virus is transmitted via tick bites or consumption of infected milk [22, 23]. The infection is characterized by a biphasic course in the primary phase, patients show signs of fatigue, headache, pain, and fever, followed by a second phase of neurological involvement with symptoms of encephalitis, meningitis, and paralysis. The mortality rate ranges from 0.5 to 30 %, with 30 to 60 % of survivors developing neurological sequelae [24–27]. Although an effective vaccine is available, treatment options are limited to supportive care . Given such high medical importance along with the increasing number of cases, and expansion into new unaffected areas, many aspects of TBEV pathogenesis and immunity are still unclear. Langat virus (LGTV) is a naturally attenuated member of TBEV serogroup . LGTV shares close molecular relationship (82–88 % amino acid identity) with TBEV and thus make it an ideal surrogate model to study TBEV pathogenesis .
We have recently shown that type I IFNs protect and control TBEV- and LGTV-induced inflammation and encephalitis by limiting systemic LGTV replication, spreading to CNS and the associated immunopathology . However, the cell types and specific PRRs involved in IFN induction and clearance of LGTV are not known.
In the current study, we have determined the relative contribution of IPS-1 signaling in LGTV disease development and protection. We show that the tropism of the virus in the CNS is shaped by the IFN response, and that IPS-1 signaling is very important for IFN-β upregulation in the olfactory bulb. The absence of IPS-1 leads to uncontrolled viral replication in CNS but plays only a minor role in shaping the humoral immune response in periphery.
All animal experiments were performed in compliance with the German animal welfare law (TierSchG BGBl. S. 1105; 25.05.1998). The mice were housed and handled in accordance with good animal practice as defined by FELASA. All animal experiments were approved by the responsible state office (Lower Saxony State Office of Consumer Protection and Food Safety) under permit number AZ 33.9-42502-04-11/0528.
Mice and viral infections
C57BL/6 wild-type (WT) mice were purchased from Harlan. IPS-1 −/− mice on the C57BL/6 background were bred under specific pathogen free conditions at the Helmholtz Centre for Infection Research. LGTV strain TP21 and TBEV strain Hypr71 (G. Dobler) were propagated in Vero B4 cells. Titers were determined by focus forming assays on Vero B4 cells . Six- to ten-week-old mice were intraperitoneally infected with the indicated focus forming units (FFU) of LGTV or TBEV in 100-μl phosphate buffered saline (PBS). For intracranial infections, mice were anesthetized by intraperitoneal injection with a mixture of ketamine (100 μg/g body weight) and xylazine (5 μg/g body weight). Mice were injected with indicated FFU of LGTV in 20 μl PBS. Mice that lost more than 20 % of their body weight were sacrificed and perfused with 10 ml of PBS. Experiments with TBEV strain Hypr were performed in the biosafety level 3 (BSL3) facility at the Helmholtz Center for Infection Research.
Focus forming assay
Viral titers were determined by using a focus forming assay as described previously . Briefly, serial dilution of virus samples were added on monolayer of Vero B4 cells in 96-well plates. After 1 h of incubation at 37 °C in a 5 % CO2, inoculum was removed and overlaid with 1.2 % Avicel RC-591 NF (FMC Biopolymer), 1× DMEM. Cell monolayers were fixed with 6 % paraformaldehyde dissolved in phosphate-buffered saline (PBS) 48 h post infection and permeabilized with 0.5 % triton X 100 and 20 mM glycine in PBS. LGTV foci were stained with monoclonal TBEV E antibody (monoclonal antiserum 1786 ) diluted 1:1000 in PBS supplemented with 10 % fetal calf serum (FCS) and 0.05 % tween 80 and horse reddish peroxidase-conjugated anti-mouse immunoglobulin (Thermo Scientific) diluted 1:2000 in PBS, 10 % FCS and 0.05 % tween 80. Antibody-bound infection foci were visualized with True BlueTM Peroxidase substrate (KPL Inc., Maryland, USA), counted under microscope, and virus titer was expressed as focus forming unit per milliliter (FFU/ml).
RNA extraction and real-time RT-PCR
RNA extraction from serum was done with QIAamp Viral RNA mini kit (QIAGEN), and LGTV levels were determine by comparing with a standard curve. The standard curve for viral RNA in serum was generated by RNA extraction, complementary DNA (cDNA) synthesis, and quantification with real-time reverse transcription PCR (RT-PCR) of control serum spiked with 1 – 105 FFU of LGTV. Mice organs were homogenized in Trizol reagent (Invitrogen) using Lysis Matrix (Nordic Biolabs) and the tissue homogenizer Fast Prep-24 (MP). The RNA was extracted using the Nucleo-Spin RNA II kit (Macherey Nagel). Five hundred nanograms of total RNA was used to synthesize cDNA with the QuantiTect Reverse Transcription Kit (Qiagen). Expression levels of mouse GAPDH, IFN-β, IFN-α4, IFN-λ, Mx1, viperin, IL6, CCL5, CXCL10, IRF1, and TRIM79α were detected by validated QuantiTect primer assays (Qiagen) and the KAPA SYBR FAST quantitative polymerase chain reaction (qPCR) Kit using the 7900HT Fast-Real-time PCR System (Applied Biosystems). Viral RNAs were detected by two different TaqMan-based assays; the TaqMan probe for TBEV  detecting the 3′ NCR with a sensitivity of 104 copies for LGTV or the newly developed LGTV NS3-based TaqMan assay, forward primer 5′-AACGGAGCCATAGCCAGTGA-3′, reverse primer 5′-AACCCGTCCCGCCACTC-3′ and probe FAM-AGAGACAGATCCCTGATGG-MGB, with a sensitivity of 10 copies. For both assays, the KAPA probe FAST qPCR kit was used. Signals of indicated messenger RNA (mRNA) or viral RNAs were normalized to the GAPDH mRNA signal.
Brain immune cell quantification
Mice brains were harvested from uninfected or LGTV-infected mice. Following perfusion, brains were homogenized through a 70-μm cell strainer, digested with a collagenase solution (500 μg/ml collagenase D, 0.1 μg/ml trypsin inhibitor TLCK, 10 μg/ml DNase I, 10 mM HEPES in HBSS) for 1 h at room temperature. Cells were separated by centrifugation on a discontinuous 70-to-30 % Percoll gradient. For the detection of resident microglia, infiltrating macrophages and dendritic cells were incubated with anti-CD45, anti-CD11b, and anti-CD11c antibodies (BD Biosciences). Infiltrating T cells were detected using anti-CD3, anti-CD4, and anti-CD8 antibodies (BD Biosciences). Brain leukocyte numbers were quantitated using TruCount beads (BD Biosciences). Analysis was performed on BD LSRII using BD FACSDiva and FlowJo software.
Immunohistological analysis were performed from WT and IPS-1 −/− mice infected with LGTV at different time points (n = 3 per time point). Brains were removed after cardiac perfusion with PBS followed by 4 % paraformaldehyde (PFA) and incubated 24 h in 4 % PFA followed by an incubation in 30 % sucrose in 0.1 M phosphate buffer for an additional 24 h. Subsequently, the brains were frozen in Tissue Tek® Compound at -80 °C. 30 μm sagittal slices of the whole brain were cut using a freezing microtome (Frigomobil, Leica, Germany). All staining procedures were performed on free floating sections. Following a 1-h blocking step at room temperature in PBS containing 1 % BSA, 0.2 % Triton, and 10 % goat serum, the slices were incubated overnight at 4 °C in primary antibody solution consisting of 10 % goat serum and 0.2 % Triton in PBS. The following antibodies were used: monoclonal TBEV E antibody (monoclonal antiserum 1786 ) monoclonal mouse anti-GFAP (Sigma, 1:500), monoclonal guinea pig anti-NeuN (SySY, 1:500), polyclonal rabbit anti-IBA1 (Synaptic System, 1:500), and polyclonal rabbit anti- cleaved caspase 3 [Asp175] (Cell Signaling, 1:400). Secondary anti-mouse, anti-guinea pig, or anti-rabbit antibodies conjugated with FITC, Cy3, or Cy5 (Jackson ImmunoResearch) were incubated 1:500 in PBS for 2 h at room temperature. All analyzed samples were comparable and support the conclusion. Representative pictures are shown.
Primary cell isolation and infection
Primary mouse hippocampal neurons were generated from WT and IPS-1 −/− mouse embryos E18 as described previously . Briefly, 70,000 dissociated hippocampal cells were seeded on poly-l-lysine coated cover slips and incubated in Neurobasal medium (Invitrogen) supplemented with 2 % B27 (Invitrogen), 1× N-2 supplement (Invitrogen) and 0.5 mM Glutamax at 37 °C, 5 % CO2, and 95 % humidity. After 2 weeks, cells were infected with LGTV (MOI-0.001) and kinetics of viral replication was recorded by focus forming assay.
Western blot analysis
For preparation of extracts, the brains or brain parts were lysed in buffer containing 250 mmol/L Tris, 0.5 % Triton X-100, and Halt protease inhibitor cocktail (Thermo Scientific, Schwerte, Germany). Western blot analysis was performed according to standard procedures. The following primary antibodies were used: Anti-STAT1-P (Tyr701, 58D6; Cell Signaling, Frankfurt, Germany), anti-STAT1 (STAT91/84; Transduction Laboratories Lexington, USA), and anti-actin (MAB 1501R, Chemicon, Limburg, Germany). Horseradish-peroxidase-conjugated anti-rabbit and anti-mouse antibodies (Amersham, Freiburg, Germany) were used as secondary antibodies using enhanced chemoluminescence detection (Bio-Rad, München, Germany). The chemiluminescence signal was recorded digitally by a ChemiDoc DRS imaging system (Bio-Rad, München, Germany). Digital signal acquisition and analysis were performed using the Quantity One Program (version 4.6; Bio-Rad, München, Germany).
IPS-1-mediated type I IFN response controls LGTV replication in the CNS but has minor role in peripheral organs
We evaluated the viral burden in the serum, peripheral organs, and the CNS of LGTV-infected WT and IPS-1 −/− mice. Quantitative real time RT-PCR analysis of viral RNA detected higher LGTV levels in serum and only low levels of LGTV in peripheral organs of IPS-1 −/− but not in WT mice (Fig. 1c–e), indicating that higher viremia in serum of IPS-1 −/− mice results in higher viral load entering the brain. The most important LGTV was readily detected 4 dpi in the brain in both WT and IPS-1 mice, indicating that LGTV has a strong tropism of the brain (Fig. 1f–g).
Consistent with the importance of IPS-1 in type I IFN induction, ELISA analysis of serum from LGTV-infected mice revealed lower IFN-α levels in IPS-1 −/− mice (Additional file 1: Figure S1). These results indicate that IPS-1 mediated IFN response control systemic viral replication and higher viral replication in the circulation leads to a higher viral load in the brain. More importantly, IPS-1 is vital for controlling LGTV replication within the CNS.
Enhanced inflammation and immune cell infiltration in the CNS of LGTV-infected IPS-1 −/− mice
We did not observe any difference in immune cell number or composition of spleen in LGTV-infected WT and IPS-1 −/− mice (Additional file 3: Figure S3. 2A–I). In addition, the neutralizing antibody response was also not changed (Additional file 3: Figure S3 2J. Additional file 4: Method S1). In overall, these data suggest that in the absence of IPS-1 signaling, LGTV replicate to higher levels in the CNS, leading to the release of inflammatory cytokines, which in turn results in a massive infiltration of immune cells to the site of inflammation and apoptosis in the brain.
IPS-1 signaling is vital for restricting LGTV replication in neurons
Local IPS-1 signaling within CNS is important for protection against LGTV infection
Different brain regions show distinct dependency on IPS-1 signaling for IFN-β production
Type I IFN response varies in neurons isolated from different brain parts . To determine if IPS-1 signaling preferentially protects a specific brain region from LGTV infection, the brain parts were analyzed for virus replication (Fig. 5b). WT and IPS-1 −/− mice were infected with LGTV intraperitoneally (104 FFU) or intracranially (102 FFU), and brain regions were harvested 4 and 7 dpi for intraperitoneal and 5 dpi for intracranial infection. Upon peripheral administration of LGTV, viral replication was restricted to the olfactory bulb in WT mice (Fig. 5b). High levels of viral replication was observed already 4 dpi in olfactory bulb in IPS-1 −/− mice compared to the other brain regions (Additional file 5: Figure S4), indicating that LGTV preferentially targets the olfactory bulb. However, in the absence of IPS-1 −/− , the infection was established earlier in the brain compared to WT. Upon 7 dpi LGTV spread to cerebrum however, the RNA levels in cerebellum and brain stem remained low. For intracranial injection, a similar trend was observed; however, the LGTV RNA levels were higher in IPS-1 −/− in all brain regions compared to WT (Fig. 5b).
Since IPS-1 signaling is important for the production of type I IFN, we analyzed mRNA levels of IFN-β in the different brain regions (Fig. 5c). Surprisingly, IFN-β mRNA levels in the cerebrum, cerebellum, and brain stem of IPS-1 −/− mice were higher or comparable to those of WT mice, indicating that IPS-1 plays only a minor role in the induction of IFN-β in these brain regions. In contrast, upon intraperitoneal infection, lower mRNA level of IFN-β (p = 0.0115) was present in the olfactory bulb of IPS-1 −/− mice compared to WT mice. Although exhibiting a higher viral titer in all brain parts, intracranially infected animals display IFN-β levels comparable to that in WT mice, indicating that IPS-1-mediated type I IFN production is limited to the olfactory bulb.
Specific role of IPS-1 signaling in antiviral response in the olfactory bulb
Protection against neurotropic LGTV infection requires coordinated action of the type I IFN system in both peripheral and CNS to prevent LGTV-induced inflammation and development of encephalitis . Here, we have characterized the function of IPS-1, a key adaptor molecule that act downstream of RLRs (RIG-I and MDA5) to activate the IFN and NF-κB pathways in LGTV infection. We have shown that IPS-1 signaling is important for controlling lethal LGTV infection. IPS-1-deficient mice show high viral replication in the peripheral and CNS, increased BBB permeability, massive infiltration of immune cells, and uncontrolled inflammation. After close analysis of different brain sections, we found that IPS-1 signaling plays a role in determining the base line levels of some antiviral ISGs but also controlling LGTV viral replication in all brain sections. Upregulation of IFN-β is specifically dependent on IPS-1 in olfactory bulb. Thus, we propose a specific role of pattern recognition receptors in the different sections of the brain in neurotropic LGTV infection.
Neuroinvasiveness and neurovirulence are key steps in the pathogenesis of neurotropic viruses. The type I IFN system is an important component of innate immunity and limits viral load of many flavivirus infections . Previously, we showed that IFNAR −/− mice succumb to LGTV infection within 5 days with uncontrolled systemic viremia . LGTV-infected IPS-1 −/− mice showed declined systemic type I IFN responses. This finding agrees with our previous studies indicating that recognition of LGTV is IPS-1-dependent  and that induction of type I IFN production by other RNA viruses is mediated by IPS-1-dependent mechanisms [45–47]. The lower systemic IFN response probably contributed to higher systemic viral levels, thus contributing to higher viral titers and earlier time point of neuroinvasiveness (Additional file 5: Figure S4 ). However, no difference in neutralizing antibody titers or spleen immune cell composition was detected. These later findings are markedly different compared to the effect seen in WNV infected IPS-1 −/− mice . Virus entry into the brain by LGTV, TBEV, and Japanese encephalitis is independent of the integrity of the BBB because virus is detectable even when the BBB is intact [30, 48, 49], and this is also true in IPS-1 deficient-mice.
The brain has distinct immune responses to pathogens and injury where resident brain cells including microglia and astrocytes, which are unique innate immune cells without direct counterparts in the periphery, can produce IFN and proinflammatory cytokines and can crosstalk with infiltrating immune cells [50–53]. Local type I IFN response is very important for controlling lethal LGTV infection in the CNS . Indeed, high levels of LGTV replication were detected in the brain of IPS-1-deficient mice compared to WT. This in turn could lead to elevated IFN-β response in the brains due to increased activation of IPS-1-independent pathways. However, increased IFN response neither led to the induction of antiviral effector genes early in infection nor was it able to control the viral infection. One explanation might be that LGTV and TBEV non-structural protein NS5 can inhibit JAK STAT pathway downstream of IFNAR to block effector functions of IFN, e.g., upregulation of ISGs [43, 44]. Accordingly, in spite of the presence of high levels of viral RNA and IFN-β in brains of IPS-1 −/− mice, day 4 post infection, STAT1 phosphorylation was not detectable and neither was ISG expression. Other studies have shown that even in the presence of type I IFN, viral replication could not be controlled and that other mechanisms like IRF-1 are essential to control viral replication . IPS-1 located on peroxisomes has been shown to induce an IRF-1-dependent IFN-independent antiviral mechanism , which has been shown to be important for both VSV and HCV [34, 55]. This pathway might be one of the reasons why IPS-1-deficient mice cannot control the LGTV infection in CNS.
Higher viral burden observed in IPS-1 −/− mice brains was a result of higher viral replication in neurons, similar to LGTV-infected TLR7 −/− mice brains . Although not highly infected, astrocytes and microglia showed an activated phenotype as evident from increased expression of GFAP and IBA-1, respectively. Astrocytes are the most abundant glial cell population in the brain and when activated could act as potential source of proinflammatory cytokines. These cytokines might contribute to BBB breakdown and TBEV induced neurotoxicity and thus play a major role in TBEV pathogenesis [57, 58]. We also detected a strong inflammatory response in the IPS-1 −/− mice leading to the opening of BBB and activation of the cell-mediated immune response with high quantity of infiltrating CD4 and CD8 T cells in later stages of infection. Although a strong T cell response was observed, it was not protective; similar findings were also seen in case of WNV . Notably rather than protection, this higher T cell response in the brain contributed to immunopathology . Apoptosis in the brains of LGTV-infected IPS-1 −/− mice were apparent as a result of high viral infection and inflammatory response, which combined ultimately lead to the death of mice.
Local immune response within the CNS plays an important role in combating viral infections . In the absence of IFNAR signaling in the CNS, LGTV replicated to higher levels and mice succumbed early to the infection . Studies with Sindbis, JEV, and WNV reports that the IPS-1 pathway is important in controlling viral replication in the brain [47, 61, 62]. Comparison of the different brain regions displays specific antiviral mechanisms [39, 63, 64]. Two neuronal subtypes, granule cell neurons of the cerebellum and cortical neurons from the cerebral cortex, have unique innate immune programs and showed differential permissiveness to replication of several positive-stranded RNA viruses . Cerebellum has also been shown to be more resistant to WNV viral infection compared to cerebrum , and this holds true for LGTV as well. One explanation for this might be an increased basal expression of ISGs such as Ifi27, Irg1, viperin, and Stat1 in granule neurons . IPS-1 signaling seems to be very important to restrict LGTV growth throughout the brain. Although, high IFN-β levels were detected in IPS-1 −/− , it could not restrict replication in any of the brain regions. Comparison of the basal expression levels of some ISGs known to be active against TBEV, LGTV, or flaviviruses in general [41, 42, 65, 66] revealed that the olfactory bulb generally shows higher levels of viperin, TRIM79α, Mx1, and IRF1 compared to cerebrum. This might play a role for defense against pathogens which enter the brain preferentially via the olfactory route. IPS-1-deficient mice have lower expression of some specific ISG but not all. Since TBEV and LGTV are very sensitive to the antiviral action of viperin  (unpublished data), this might be one of the contributing reasons why IPS-1-deficient mice are more susceptible to LGTV infection. This initial advantage might also contribute to higher levels of viral NS5 and inhibition of STAT1 phosphorylation in IPS-1 deficient mice. This is in contrast to wild-type mice that have higher basal levels of antiviral ISGs, respond faster by production of IFN-β, and have a more robust STAT1-mediated expression of ISGs required to contain the infection. Notably, LGTV infection was restricted to olfactory bulb in WT mice. Similar observations were made in VSV and cytomegalovirus (CMV) infections. VSV- and CMV-induced long-distance interferon signaling within the brain that blocks virus spread  and astrocytes were found to be the main producer of IFN-β in the olfactory bulb in response to VSV infection . In LGTV infection, the olfactory bulb seems to be more dependent on IPS-1 signaling for IFN-β production compared to the other brain parts, where RLR independent pathways (MyD88 and TRIF) compensated with higher IFN-β production. Thus, different cell types might exert specific immune response in different sections of the brain.
In summary, IPS-1 signaling is important to coordinate and shape the innate immune response within the peripheral and CNS during LGTV infection. In our study, we show that some antiviral ISGs have lower basal expression levels in IPS-1 deficient mice, which may contribute to a higher viral burden. We also show that IPS-1 signaling is more important for IFN-β production in olfactory bulb compared to the other brain regions. We propose that various PRR pathways regulate the IFN response within different sections of the brain. To this end, further studies are underway to determine what cell types and antiviral factors govern the differential role of PRRs in the different regions of the brain during LGTV and TBEV infections. This study will contribute to the understanding of regional immunological diversity within the CNS and its impact on neurotropic virus infections.
We thank Gerhard Dobler from the Bundeswehr Institute of Microbiology (Munich, Germany) for providing the virus strains Langat virus TP21 and TBEV strain Hypr71. We also thank Martina Grashoff for the excellent technical assistance. This work was supported by the Kempe Foundations, the Laboratory for Molecular Medicine Sweden (MIMS), the Umeå Center for Microbial Research (UCMR) and Linneus Support, the Jeanssons Foundations, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (A.K.Ö.), and the Helmholtz International Research School for Infection Biology (HIRSIB) (A.K.).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918–21.PubMedView ArticleGoogle Scholar
- Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol. 2000;74(11):4957–66.PubMedPubMed CentralView ArticleGoogle Scholar
- Leyssen P, Drosten C, Paning M, Charlier N, Paeshuyse J, De Clercq E, et al. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob Agents Chemother. 2003;47(2):777–82.PubMedPubMed CentralView ArticleGoogle Scholar
- Lobigs M, Mullbacher A, Wang Y, Pavy M, Lee E. Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J Gen Virol. 2003;84(Pt 3):567–72.PubMedView ArticleGoogle Scholar
- Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79(21):13350–61.PubMedPubMed CentralView ArticleGoogle Scholar
- Silva MC, Guerrero-Plata A, Gilfoy FD, Garofalo RP, Mason PW. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol. 2007;81(24):13640–8.PubMedPubMed CentralView ArticleGoogle Scholar
- Daffis S, Samuel MA, Keller BC, Gale Jr M, Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007;3(7):e106.PubMedPubMed CentralView ArticleGoogle Scholar
- Biswas M, Kumar SR, Allen A, Yong W, Nimmanapalli R, Samal SK, et al. Cell-type-specific innate immune response to oncolytic Newcastle disease virus. Viral Immunol. 2012;25(4):268–76.PubMedPubMed CentralView ArticleGoogle Scholar
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.PubMedView ArticleGoogle Scholar
- Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004;5(7):730–7.PubMedView ArticleGoogle Scholar
- Sumpter Jr R, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol. 2005;79(5):2689–99.PubMedPubMed CentralView ArticleGoogle Scholar
- Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005;6(10):981–8.PubMedView ArticleGoogle Scholar
- Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122(5):669–82.PubMedView ArticleGoogle Scholar
- Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell. 2005;19(6):727–40.PubMedView ArticleGoogle Scholar
- Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437(7062):1167–72.PubMedView ArticleGoogle Scholar
- Sen GC. Viruses and interferons. Annu Rev Microbiol. 2001;55:255–81.PubMedView ArticleGoogle Scholar
- Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nature reviews. 2008;8(7):559–68.PubMedPubMed CentralGoogle Scholar
- Detje CN, Lienenklaus S, Chhatbar C, Spanier J, Prajeeth CK, Soldner C, et al. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis. J Virol. 2015;89(5):2731–8.PubMedPubMed CentralView ArticleGoogle Scholar
- Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol. 2012;86(20):11223–30.PubMedPubMed CentralView ArticleGoogle Scholar
- Kallfass C, Lienenklaus S, Weiss S, Staeheli P. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol. 2013;87(12):6925–30.PubMedPubMed CentralView ArticleGoogle Scholar
- Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus flavivirus. J Virol. 1998;72(1):73–83.PubMedPubMed CentralGoogle Scholar
- Kerbo N, Donchenko I, Kutsar K, Vasilenko V. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Euro Surveill. 2005;10(6):E050623. 2.PubMedGoogle Scholar
- Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis. 1999;28(4):882–90.PubMedView ArticleGoogle Scholar
- Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res. 2003;57(1-2):129–46.PubMedView ArticleGoogle Scholar
- Heinz FX, Kunz C. Tick-borne encephalitis and the impact of vaccination. Arch Virol Suppl. 2004;18:201–5.PubMedGoogle Scholar
- Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371(9627):1861–71.PubMedView ArticleGoogle Scholar
- Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T. Tick-borne encephalitis virus—a review of an emerging zoonosis. J Gen Virol. 2009;90(Pt 8):1781–94.PubMedView ArticleGoogle Scholar
- Lani R, Moghaddam E, Haghani A, Chang LY, AbuBakar S, Zandi K. Tick-borne viruses: a review from the perspective of therapeutic approaches. Ticks Tick Borne Dis. 2014;5(5):457–65.PubMedView ArticleGoogle Scholar
- Maximova OA, Ward JM, Asher DM, St Claire M, Finneyfrock BW, Speicher JM, et al. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J Virol. 2008;82(11):5255–68.PubMedPubMed CentralView ArticleGoogle Scholar
- Weber E, Finsterbusch K, Lindquist R, Nair S, Lienenklaus S, Gekara NO, et al. Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses. J Virol. 2014;88(21):12202–12.PubMedPubMed CentralView ArticleGoogle Scholar
- Overby AK, Popov VL, Niedrig M, Weber F. Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol. 2010;84(17):8470–83.PubMedPubMed CentralView ArticleGoogle Scholar
- Niedrig M, Klockmann U, Lang W, Roeder J, Burk S, Modrow S, et al. Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo. Acta Virol. 1994;38(3):141–9.PubMedGoogle Scholar
- Schwaiger M, Cassinotti P. Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA. J Clin Virol. 2003;27(2):136–45.PubMedView ArticleGoogle Scholar
- Nair S, Michaelsen-Preusse K, Finsterbusch K, Stegemann-Koniszewski S, Bruder D, Grashoff M, et al. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog. 2014;10(3):e1003999.PubMedPubMed CentralView ArticleGoogle Scholar
- Gottfried-Blackmore A, Kaunzner UW, Idoyaga J, Felger JC, McEwen BS, Bulloch K. Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proc Natl Acad Sci U S A. 2009;106(49):20918–23.PubMedPubMed CentralView ArticleGoogle Scholar
- Prikhod’ko GG, Prikhod’ko EA, Cohen JI, Pletnev AG. Infection with Langat flavivirus or expression of the envelope protein induces apoptotic cell death. Virology. 2001;286(2):328–35.PubMedView ArticleGoogle Scholar
- Ruzek D, Vancova M, Tesarova M, Ahantarig A, Kopecky J, Grubhoffer L. Morphological changes in human neural cells following tick-borne encephalitis virus infection. J Gen Virol. 2009;90(Pt 7):1649–58.PubMedView ArticleGoogle Scholar
- Lee VM, Pixley SK. Age and differentiation-related differences in neuron-specific tubulin immunostaining of olfactory sensory neurons. Brain Res Dev Brain Res. 1994;83(2):209–15.PubMedView ArticleGoogle Scholar
- Cho H, Proll SC, Szretter KJ, Katze MG, Gale Jr M, Diamond MS. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013;19(4):458–64.PubMedPubMed CentralView ArticleGoogle Scholar
- Robertson SJ, Lubick KJ, Freedman BA, Carmody AB, Best SM. Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function. J Immunol. 2014;192(6):2744–55.PubMedPubMed CentralView ArticleGoogle Scholar
- Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, Bresnahan WA, et al. TRIM79alpha, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe. 2011;10(3):185–96.PubMedPubMed CentralView ArticleGoogle Scholar
- Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL, Dobler G, et al. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol. 2014;16(6):834–48.PubMedView ArticleGoogle Scholar
- Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol. 2005;79(20):12828–39.PubMedPubMed CentralView ArticleGoogle Scholar
- Werme K, Wigerius M, Johansson M. Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling. Cell Microbiol. 2008;10(3):696–712.PubMedView ArticleGoogle Scholar
- Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 2010;6(7):e1001016.PubMedPubMed CentralView ArticleGoogle Scholar
- Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med. 2006;203(7):1795–803.PubMedPubMed CentralView ArticleGoogle Scholar
- Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010;6(2):e1000757.PubMedPubMed CentralView ArticleGoogle Scholar
- Li F, Wang Y, Yu L, Cao S, Wang K, Yuan J, et al. Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection. J Virol. 2015;89(10):5602–14.PubMedPubMed CentralView ArticleGoogle Scholar
- Ruzek D, Salat J, Singh SK, Kopecky J. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells. PLoS ONE. 2011;6(5):e20472.PubMedPubMed CentralView ArticleGoogle Scholar
- Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48–65.PubMedPubMed CentralView ArticleGoogle Scholar
- Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A. 2006;103(20):7835–40.PubMedPubMed CentralView ArticleGoogle Scholar
- Rivest S. Regulation of innate immune responses in the brain. Nature reviews. 2009;9(6):429–39.PubMedGoogle Scholar
- Nair S, Diamond MS. Innate immune interactions within the central nervous system modulate pathogenesis of viral infections. Curr Opin Immunol. 2015;36:47–53.PubMedView ArticleGoogle Scholar
- Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 2010;141(4):668–81.PubMedPubMed CentralView ArticleGoogle Scholar
- Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, et al. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Gastroenterology. 2013;145(6):1414–23. e1.PubMedView ArticleGoogle Scholar
- Baker DG, Woods TA, Butchi NB, Morgan TM, Taylor RT, Sunyakumthorn P, et al. Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection. J Gen Virol. 2013;94(Pt 2):336–47.PubMedPubMed CentralView ArticleGoogle Scholar
- Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003;26(10):523–30.PubMedView ArticleGoogle Scholar
- Palus M, Bily T, Elsterova J, Langhansova H, Salat J, Vancova M, et al. Infection and injury of human astrocytes by tick-borne encephalitis virus. J Gen Virol. 2014;95(Pt 11):2411–26.PubMedView ArticleGoogle Scholar
- Ruzek D, Salat J, Palus M, Gritsun TS, Gould EA, Dykova I, et al. CD8+ T-cells mediate immunopathology in tick-borne encephalitis. Virology. 2009;384(1):1–6.PubMedView ArticleGoogle Scholar
- Griffin DE. Immune responses to RNA-virus infections of the CNS. Nature reviews. 2003;3(6):493–502.PubMedGoogle Scholar
- Nazmi A, Dutta K, Basu A. RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS ONE. 2011;6(6):e21761.PubMedPubMed CentralView ArticleGoogle Scholar
- Wollish AC, Ferris MT, Blevins LK, Loo YM, Gale Jr M, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology. 2013;435(2):269–80.PubMedPubMed CentralView ArticleGoogle Scholar
- Archambault AS, Sim J, McCandless EE, Klein RS, Russell JH. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006;181(1-2):122–32.PubMedView ArticleGoogle Scholar
- Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 2012;8(5):e1002712.PubMedPubMed CentralView ArticleGoogle Scholar
- Pavlovic J, Haller O, Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol. 1992;66(4):2564–9.PubMedPubMed CentralGoogle Scholar
- Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–5.PubMedPubMed CentralView ArticleGoogle Scholar
- van den Pol AN, Ding S, Robek MD. Long-distance interferon signaling within the brain blocks virus spread. J Virol. 2014;88(7):3695–704.PubMedPubMed CentralView ArticleGoogle Scholar
- Vene S, Haglund M, Vapalahti O, Lundkvist A. A rapid fluorescent focus inhibition test for detection of neutralizing antibodies to tick-borne encephalitis virus. J Virol Methods. 1998;73(1):71–5.PubMedView ArticleGoogle Scholar
- Kostense S, Moore S, Companjen A, Bakker AB, Marissen WE, von Eyben R, et al. Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples. Antimicrob Agents Chemother. 2012;56(7):3524–30.PubMedPubMed CentralView ArticleGoogle Scholar